The incidence of venous thromboembolism (VTE) after cancer surgery is about two-fold higher than after similar non-cancer surgery, with an incidence of fatal pulmonary embolism that is about three-fold higher than that associated with non-cancer surgery [1]. In-hospital heparin prophylaxis is effective in reducing deep vein thrombosis and fatal pulmonary embolism after cancer surgery [2].
